Association of SCN1A, SCN2A, and UGT2B7 Polymorphisms with Responsiveness to Valproic Acid in the Treatment of Epilepsy

Table 1

Basic characteristics of the epileptic patients.

Characteristics	VPA responsive ()	VPA resistant ()	Total ()	value
Age (years)				0.373
Dose (mg)				0.103
Gender
Male	65 (72.2)	18 (75.0)	83 (72.8)	0.989
Female	25 (27.8)	6 (25.0)	31 (27.2)
Etiology
Idiopathic	68 (75.6)	13 (54.2)	81 (71.1)	0.122
Symptomatic	20 (22.2)	10 (41.7)	30 (26.3)
Cryptogenic	2 (2.2)	1 (4.2)	3 (2.6)

Data were presented as or (%). VPA: valproic acid.